| Hans-Günter Meyer-Thompson | Hepatitiden
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study
Isfordink, Cas J et al.
The Lancet Public Health, Volume 8, Issue 4, e294 - e304
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(23)00056-7/fulltext